Prospective Evaluation of Computerized Physician Order Entry in the Emergency Department (CPOE)
|ClinicalTrials.gov Identifier: NCT01444768|
Recruitment Status : Withdrawn
First Posted : October 3, 2011
Last Update Posted : April 5, 2017
|Condition or disease||Intervention/treatment|
|Operational Metrics of the Emergency Department||Other: Computerized Physician Order Entry|
The study will be a prospective before-after study comparing various operational and performance metrics before and after the implementation of a computerized physician order entry system in the emergency department.
The investigators will collect 6 month before, 6 month after of data along with a 2-4 week washout period. The investigators will also administer a computerized physician order entry survey after the study is completed. This confidential survey will be emailed to all ED nurses, residents, and attendings using RedCap. Consent will be implied if they choose to participate.
|Study Type :||Observational|
|Actual Enrollment :||0 participants|
|Official Title:||Prospective Evaluation of Computerized Physician Order Entry in the Emergency Department|
|Study Start Date :||March 2012|
|Estimated Primary Completion Date :||December 2012|
|Estimated Study Completion Date :||December 2013|
Other: Computerized Physician Order Entry
- Time to Antibiotics [ Time Frame: 6 months ]Primary outcome measure is time to antibiotics. This is defined as the time patients are registered to the time they receive their first antibiotics for patients with an ED diagnosis of pneumonia.
- Emergency Department Length of Stay [ Time Frame: 6 months ]Secondary outcome measure is length of stay defined as the time from patient registration to time the patients leave the emergency department.
- Lab turnaround time [ Time Frame: 6 months ]Lab turnaround time is defined as the time it takes from when the sample is collected to when the results are entered.
- Resource Utilization [ Time Frame: 6 months ]Resource utilization defined as the number of CBC, Chem7, and troponin tests ordered.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01444768
|United States, Massachusetts|
|Beth Israel Deaconess Medical Center|
|Boston, Massachusetts, United States, 02215|
|Principal Investigator:||Steven Horng, MD||Beth Israel Deaconess Medical Center|